Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney/Urinary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01844947
What this trial is testing

Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract

Who this might be right for
Urothelial CarcinomaBladder CancerRenal Pelvis Cancer+2 more
Dr Anders Ullén 22
Not applicableStudy completedNCT06582849
What this trial is testing

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

Who this might be right for
Bone CancerBrain CancerColorectal Cancer+24 more
Washington University School of Medicine 33
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Not applicableUnknownNCT05135832
What this trial is testing

Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell CarcinomaKidney CancerKidney Neoplasm+3 more
Herlev and Gentofte Hospital 174
Testing effectiveness (Phase 2)Study completedNCT00045630
What this trial is testing

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 77
Early research (Phase 1)Study completedNCT01182168
What this trial is testing

Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Bladder CancerRenal Pelvis CancerUreter Cancer
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00002914
What this trial is testing

Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group 40
Not applicableUnknownNCT02292914
What this trial is testing

Prospective Analysis of Robot-Assisted Surgery

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+7 more
Instituto do Cancer do Estado de São Paulo 1,120
Not applicableStudy completedNCT04933604
What this trial is testing

LPN in Patients With High-complex Renal Tumors

Who this might be right for
Renal CancerRenal NeoplasmRenal Cell Carcinoma+7 more
Samsun Liv Hospital 78
Not applicableUnknownNCT04718948
What this trial is testing

Multimodal Spectroscopy to Detect Urothelial Cancer in Urine

Who this might be right for
Urothelial CarcinomaUrinary Bladder CancerUrinary Tract Cancer
University of Florence 500
Testing effectiveness (Phase 2)Looking for participantsNCT06580002
What this trial is testing

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Who this might be right for
Breast CancerSarcomaGastric Cancer+19 more
University of California, Irvine 75
Early research (Phase 1)Study completedNCT03617003
What this trial is testing

Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11)

Who this might be right for
Upper Tract Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00004203
What this trial is testing

Oxaliplatin in Treating Patients With Metastatic Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
University of Chicago 20
Large-scale testing (Phase 3)Looking for participantsNCT06349668
What this trial is testing

Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery

Who this might be right for
Other Specified Disorders of Kidney and UreterBenign Neoplasm of UreterCalculus of Kidney and Ureter+5 more
Hans Bahlmann 220
Not applicableStudy completedNCT02742597
What this trial is testing

Patient-Centred Innovations for Persons With Multimorbidity - Ontario

Who this might be right for
HypertensionDepressionAnxiety+28 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 175
Not applicableActive Not RecruitingNCT06408597
What this trial is testing

Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy

Who this might be right for
Prostate CancerBladder CancerSurgery+2 more
Nazmy Edward Seif 90
Not applicableUnknownNCT02496442
What this trial is testing

Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan

Who this might be right for
Prostatic HyperplasiaKidney CalculiBladder Tumors
Flowmed 30
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Looking for participantsNCT03866382
What this trial is testing

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Who this might be right for
Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more
National Cancer Institute (NCI) 314
Testing effectiveness (Phase 2)Looking for participantsNCT06161532
What this trial is testing

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Who this might be right for
Small Cell Carcinoma of the BladderSmall Cell Carcinoma of the Urinary TractSquamous Cell Carcinoma of the Bladder+5 more
National Cancer Institute (NCI)
Next Page
60